Rating History for Karyopharm Therapeutics (KPTI) by Morgan Stanley

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/3/2020 David Lebowitz Maintain Overweight
(N/A)
32.00
(31.00)
 
 
  Details